FITC Anti-Human CD22 Antibody[BU59]

The FITC Anti-Human CD22 Antibody[BU59] is a highly specific and sensitive monoclonal antibody that has been designed for use in a variety of research applications. This antibody is specifically designed to target the CD22 antigen, which is a transmembrane glycoprotein that is expressed on the surface of B cells. The antibody has been conjugated with fluorescein isothiocyanate (FITC), which allows for easy detection and visualization of the CD22 antigen.

The FITC Anti-Human CD22 Antibody[BU59] has been extensively tested and validated for use in flow cytometry, immunofluorescence, and immunohistochemistry applications. It has been shown to be highly specific for the CD22 antigen, with minimal cross-reactivity with other antigens. This antibody has also been shown to be highly sensitive, with the ability to detect low levels of CD22 expression.

This antibody is supplied in a convenient format, with a concentration of 0.5 mg/ml. It is provided in a phosphate-buffered saline (PBS) solution, which ensures stability and compatibility with a wide range of experimental conditions. The antibody has also been purified using a proprietary process that ensures high purity and minimal background staining.

Overall, the FITC Anti-Human CD22 Antibody[BU59] is a highly reliable and effective tool for researchers studying B cell biology and related fields. Its high specificity and sensitivity make it an ideal choice for a wide range of applications, and its convenient format and high purity ensure consistent and reproducible results.